GlobalData on MSN
MSD receives FDA approval for Winrevair’s updated indication
MSD has received US Food and Drug Administration (FDA) approval for an updated indication of Winrevair (sotatercept-csrk) for ...
Clinical Trials Arena on MSN
MSD and Eisai to end Phase III LEAP-012 trial for unresectable HCC
M erck & Co (MSD) and Eisai are set to discontinue their Phase III clinical trial for unresectable, non‑metastatic ...
MSD and Eisai presented the data at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The ...
Along with Verona, MSD has been adding to its post-Keytruda prospects with a string of acquisitions and licensing deals in ...
MSD, known as Merck & Co in the US and Canada, licensed rights to Lenvima in 2018 in a near-$6 billion deal aimed at developing it as a partner drug to Keytruda. The combination has been approved for ...
Pharmaceutical Technology on MSN
MSD initiates construction on $3bn Virginia drug manufacturing site
Merck's (MSD) $3bn Virginia facility is part of the big pharma's $70bn US R&D and manufacturing expansion pledge.
MSD is investing in East West Manufacturing, an Atlanta-based engineering and manufacturing services company. No financial terms were disclosed. ATLANTA, GA – February 1, 2022 – East West ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback